Durham drugmaker banks $3.5 million to enhance flu treatment

A Triangle firm developing a drug that targets the immune response to influenza and similar conditions has banked millions in its latest fundraising round.

Source: bizjournals.com Health Care:Biotechnology headlines - October 22, 2020 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news